-
Something wrong with this record ?
Příští generace léčiv snižujících triglyceridy: pomůže snížení koncentrací apolipoproteinu C-III nebo angiopoietin-like proteinu 3 snížit incidenci kardiovaskulárních onemocnění? [Next generation of triglyceride-lowering drugs: will reducing apolipoprotein C-III or angiopoietin like protein 3 reduce cardiovascular disease?]
Laurens F. Reeskamp, Tycho R. Tromp, Erik S. G. Stroes
Current Opinion in Lipidology.
2020 ;
8 (2) :
42-49.
Language Czech Country Czech Republic
Document type Review
Persistent link
https://www.medvik.cz/link/bmc21005524
- MeSH
- Angiopoietin-like Proteins antagonists & inhibitors genetics MeSH
- Angiopoietin-Like Protein 3 MeSH
- Oligonucleotides, Antisense therapeutic use MeSH
- Apolipoprotein C-III * antagonists & inhibitors genetics MeSH
- Hypertriglyceridemia drug therapy genetics metabolism MeSH
- Cardiovascular Diseases drug therapy genetics metabolism MeSH
- Clinical Trials as Topic MeSH
- Humans MeSH
- Triglycerides antagonists & inhibitors genetics metabolism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Review MeSH
Next generation of triglyceride-lowering drugs: will reducing apolipoprotein C-III or angiopoietin like protein 3 reduce cardiovascular disease?
Citace: Current Opinion in Lipidology: June 2020 - Volume 31 - Issue 3 - p 140-146 doi: 10.1097/MOL.0000000000000679
Bibliography, etc.Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21005524
- 003
- CZ-PrNML
- 005
- 20220727144754.0
- 007
- ta
- 008
- 210223s2020 xr ad f 000 0|cze||
- 009
- AR
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a cze
- 044 __
- $a xr
- 100 1_
- $a Reeskamp, Laurens F. $u Department of Vascular Medicine, Amsterdam UMC, Amsterdam, The Netherlands
- 245 10
- $a Příští generace léčiv snižujících triglyceridy: pomůže snížení koncentrací apolipoproteinu C-III nebo angiopoietin-like proteinu 3 snížit incidenci kardiovaskulárních onemocnění? / $c Laurens F. Reeskamp, Tycho R. Tromp, Erik S. G. Stroes
- 246 31
- $a Next generation of triglyceride-lowering drugs: will reducing apolipoprotein C-III or angiopoietin like protein 3 reduce cardiovascular disease?
- 500 __
- $a Citace: Current Opinion in Lipidology: June 2020 - Volume 31 - Issue 3 - p 140-146 doi: 10.1097/MOL.0000000000000679
- 504 __
- $a Literatura
- 650 _7
- $a angiopoetinu podobný protein 3 $7 D000091303 $2 czmesh
- 650 _7
- $a angiopoetinu podobné proteiny $x antagonisté a inhibitory $x genetika $7 D000075802 $2 czmesh
- 650 17
- $a apolipoprotein C-III $x antagonisté a inhibitory $x genetika $7 D053305 $2 czmesh
- 650 _7
- $a kardiovaskulární nemoci $x farmakoterapie $x genetika $x metabolismus $7 D002318 $2 czmesh
- 650 _7
- $a hypertriglyceridemie $x farmakoterapie $x genetika $x metabolismus $7 D015228 $2 czmesh
- 650 _7
- $a antisense oligonukleotidy $x terapeutické užití $7 D016376 $2 czmesh
- 650 _7
- $a triglyceridy $x antagonisté a inhibitory $x genetika $x metabolismus $7 D014280 $2 czmesh
- 650 _7
- $a klinické zkoušky jako téma $7 D002986 $2 czmesh
- 650 _7
- $a lidé $7 D006801 $2 czmesh
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Tromp, Tycho R. $u Department of Vascular Medicine, Amsterdam UMC, Amsterdam, The Netherlands
- 700 1_
- $a Stroes, Erik S. G. $u Department of Vascular Medicine, Amsterdam UMC, Amsterdam, The Netherlands
- 773 0_
- $t Current Opinion in Lipidology $x 1802-372X $g Roč. 8, č. 2 (2020), s. 42-49 $w MED00156015
- 910 __
- $a ABA008 $b B 2483 $c 129 $y p $z 0
- 990 __
- $a 20210223085641 $b ABA008
- 991 __
- $a 20220727144750 $b ABA008
- 999 __
- $a ok $b bmc $g 1624466 $s 1125848
- BAS __
- $a 3
- BMC __
- $a 2020 $b 8 $c 2 $d 42-49 $i 1802-372X $m Current Opinion in Lipidology $x MED00156015
- LZP __
- $c NLK182 $d 20220727 $a NLK 2021-01/mk
